Viral response guided therapy for hepatitis C in the approaching era of direct acting anti-viral agents

J Gastroenterol Hepatol. 2010 Apr;25(4):655-6. doi: 10.1111/j.1440-1746.2010.06283.x.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Biomarkers / blood
  • Drug Therapy, Combination
  • Genotype
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / diagnosis*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Phenotype
  • Polyethylene Glycols / therapeutic use
  • Precision Medicine
  • Predictive Value of Tests
  • RNA, Viral / blood*
  • Recombinant Proteins
  • Ribavirin / therapeutic use
  • Time Factors
  • Treatment Outcome
  • Viral Load*

Substances

  • Antiviral Agents
  • Biomarkers
  • Interferon alpha-2
  • Interferon-alpha
  • RNA, Viral
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a